Canada Pension Plan Investment Board Exact Sciences Corp Transaction History

Canada Pension Plan Investment Board

  • $98.7 Billion
  • Q3 2024

A detailed history of Canada Pension Plan Investment Board transactions in Exact Sciences Corp stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 2,300 shares of EXAS stock, worth $133,653. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,300
Previous 97,300 97.64%
Holding current value
$133,653
Previous $4.11 Million 96.2%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$42.43 - $70.83 $4.03 Million - $6.73 Million
-95,000 Reduced 97.64%
2,300 $156,000
Q2 2024

Aug 12, 2024
SELL
$41.33 - $74.26 $5.37 Million - $9.65 Million
-129,900 Reduced 57.17%
97,300 $4.11 Million
Q1 2024

May 14, 2024
BUY
$56.27 - $73.77 $4.38 Million - $5.74 Million
77,800 Added 52.07%
227,200 $15.7 Million
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $5.34 Million - $6.85 Million
90,500 Added 153.65%
149,400 $11.1 Million
Q3 2023

Nov 09, 2023
SELL
$65.94 - $99.04 $909,972 - $1.37 Million
-13,800 Reduced 18.98%
58,900 $4.02 Million
Q2 2023

Aug 09, 2023
BUY
$62.68 - $95.05 $4.56 Million - $6.91 Million
72,700 New
72,700 $6.83 Million
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $5.58 Million - $9.77 Million
-183,730 Reduced 98.17%
3,420 $169,000
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $3.47 Million - $5.35 Million
108,393 Added 137.63%
187,150 $6.08 Million
Q2 2022

Aug 12, 2022
SELL
$35.61 - $76.23 $2.09 Million - $4.47 Million
-58,630 Reduced 42.68%
78,757 $3.1 Million
Q1 2022

May 13, 2022
BUY
$57.56 - $82.54 $2,590 - $3,714
45 Added 0.03%
137,387 $9.61 Million
Q4 2021

Feb 14, 2022
SELL
$72.5 - $100.68 $1.47 Million - $2.04 Million
-20,215 Reduced 12.83%
137,342 $10.7 Million
Q3 2021

Nov 15, 2021
SELL
$90.24 - $124.05 $473,399 - $650,766
-5,246 Reduced 3.22%
157,557 $15 Million
Q2 2021

Aug 16, 2021
SELL
$93.66 - $139.27 $5.57 Million - $8.28 Million
-59,477 Reduced 26.76%
162,803 $20.2 Million
Q1 2021

May 17, 2021
BUY
$116.57 - $155.01 $5.72 Million - $7.6 Million
49,046 Added 28.31%
222,280 $29.3 Million
Q4 2020

Feb 17, 2021
SELL
$99.61 - $142.12 $91,143 - $130,039
-915 Reduced 0.53%
173,234 $23 Million
Q3 2020

Nov 12, 2020
BUY
$72.92 - $102.01 $3,208 - $4,488
44 Added 0.03%
174,149 $17.8 Million
Q2 2020

Aug 14, 2020
SELL
$55.75 - $92.75 $2.56 Million - $4.27 Million
-45,987 Reduced 20.89%
174,105 $15.1 Million
Q1 2020

May 13, 2020
BUY
$37.9 - $104.44 $3.88 Million - $10.7 Million
102,432 Added 87.06%
220,092 $12.8 Million
Q4 2019

Feb 14, 2020
SELL
$77.66 - $99.74 $2.41 Million - $3.1 Million
-31,076 Reduced 20.89%
117,660 $10.9 Million
Q3 2019

Nov 12, 2019
BUY
$90.37 - $122.49 $9.88 Million - $13.4 Million
109,283 Added 277.0%
148,736 $13.4 Million
Q2 2019

Aug 12, 2019
SELL
$89.51 - $118.04 $1.01 Million - $1.33 Million
-11,281 Reduced 22.24%
39,453 $4.66 Million
Q1 2019

May 15, 2019
BUY
$61.98 - $96.5 $3.14 Million - $4.9 Million
50,734 New
50,734 $4.4 Million
Q2 2018

Aug 07, 2018
SELL
$37.84 - $69.96 $1.79 Million - $3.3 Million
-47,200 Closed
0 $0
Q1 2018

May 14, 2018
SELL
$39.82 - $57.53 $35.7 Million - $51.5 Million
-895,500 Reduced 94.99%
47,200 $1.9 Million
Q4 2017

Feb 14, 2018
BUY
$46.49 - $60.51 $590,423 - $768,477
12,700 Added 1.37%
942,700 $49.5 Million
Q3 2017

Oct 30, 2017
BUY
$37.05 - $47.12 $16.9 Million - $21.4 Million
455,000 Added 95.79%
930,000 $43.8 Million
Q2 2017

Jan 31, 2018
BUY
N/A
436,700 Added 1140.21%
475,000 $16.8 Million
Q1 2017

Jan 31, 2018
BUY
N/A
38,300
38,300 $905,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email